4//SEC Filing
CAIN CHRISTOPHER W. 4
Accession 0000950170-25-037965
CIK 0001590750other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:19 PM ET
Size
6.3 KB
Accession
0000950170-25-037965
Insider Transaction Report
Form 4
CAIN CHRISTOPHER W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-10+42,000→ 42,000 total(indirect: See Footnote)Exercise: $15.58Exp: 2035-03-10→ Common Stock (42,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.
- [F2]Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the "Adviser"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001817733
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:19 PM ET
- Size
- 6.3 KB